Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06226493 · ClinicalTrials.gov registry record · NA
EEG Changes and DNA Markers Related to taVNS in Stroke Patients: a Preliminary Study
A NA study, sponsored by Casa Colina Hospital and Centers for Healthcare.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT06226493 is a NA study that is actively recruiting participants, run by Casa Colina Hospital and Centers for Healthcare. The registered enrollment target is 44 participants.
The verdict
NCT06226493, a NA study, is actively recruiting participants, sponsored by Casa Colina Hospital and Centers for Healthcare.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
In the United States, more than 795,000 people have a stroke every year. Motor impairment after a stroke is common and can be debilitating. To date, there remain few treatments available to help improve motor recovery after a stroke, making this an important area of research. Novel use of neuromodulation such as Invasive Vagus Nerve Stimulation (VNS) has been shown to improve motor recovery in stroke patients. Vagus nerve stimulation (VNS), in which the nerve is stimulated with electrical pulses, has demonstrated success for a variety of conditions, including inflammation, depression, cognitive dysfunction, chronic fatigue, headaches/migraines, pain, insomnia, and cardiovascular issues. Very recently, non-invasive options have been developed and might be a promising alternative. The research in this area is still very limited and much more research is needed to investigate non-invasive/trancutaneous auricular vagus nerve stimulation (taVNS) related biomechanisms and to further support its efficacy in acute patients. The purpose of this study is to build upon the current research to investigate changes in electrical brain activity (using electrophysiology) and genetic markers related to improvements in both motor and cognitive recovery following the use of taVNS vs. sham in acute stroke patients.
Interventions
- DEVICE Transcutaneous vagus nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06226493
The ClinicalTrials.gov registry entry for NCT06226493 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Casa Colina Hospital and Centers for Healthcare, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous vagus nerve stimulation is the first listed.
NCT06226493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06226493 about?
NCT06226493 is a clinical study titled "EEG Changes and DNA Markers Related to taVNS in Stroke Patients: a Preliminary Study". In the United States, more than 795,000 people have a stroke every year. Motor impairment after a stroke is common and can be debilitating. To date, there remain few treatments available to help improve motor recovery after a stroke, making this an important area of research. Novel use of neuromodul...
What is the current status of trial NCT06226493?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2024-01-29. Estimated completion is 2027-01-30.
What interventions are being tested in trial NCT06226493?
The interventions under investigation include: Transcutaneous vagus nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT06226493?
This trial is sponsored by Casa Colina Hospital and Centers for Healthcare, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.